EBioMedicine 2 (2015) 1312–1313
Contents lists available at ScienceDirect
EBioMedicine
journal homepage: www.ebiomedicine.com
Commentary
Mir-661: A key Factor in Embryo-Maternal dialog With Potential Clinical
Application to Predict Implantation Outcome?
Antonio Cano a,b, Raul Gomez c,⁎
a
b
c
Service of Obstetrics and Gynecology, Hospital Clínico Universitario, 46010 Valencia, Spain
Department of Pediatrics, Obstetrics and Gynecology, Universidad de Valencia, 46010 Valencia, Spain
Instituto Universitario IVI/INCLIVA, Valencia, 46015, Spain
Implantation resulting in a full-term pregnancy is, by large, more
than a passive process in which the developed conceptus is passively
glued to the uterus through adhesive molecules. It is the result of a perfectly orchestrated dialog between a viable embryo and a receptive endometrium, through a mixture of paracrine and juxtacrine processes in
which many key proteins and growth factors play fundamental roles
(Pellicer et al., 2002.) Since their discovery, microRNAs have become
prominent regulatory candidates, providing missing links for a few biological pathways in this process, although their exact role in human normal embryo formation and endometrial preparation for pregnancy
remains unclear (Galliano and Pellicer, 2014). Very recently it was
shown, that human endometrium delivers miRNA messages “bottled”
in protective structures such us exosomes (Ng et al., 2013) to exert a biological function in the recipient embryo (Balaguer et al., 2015). In this
issue, Cuman et al (Cuman et al., 2015) show that miRNA also travel in
the opposite way: secreted by the embryo to alter endometrial epithelial adhesion. More specifically, authors show that miR-661 can be found
to be differentially over-represented in culture media of embryos which
failed to implant. Subsequently they show that mir661 is taken up by
primary human endometrial epithelial cells (HEEC) inducing the inhibition of nectin 1 (a protein mediating cell adhesion) in endometrial cells
and this results in reduced attachment of trophoblast cell line spheroids
to HEEC. Provided that in-silico analysis showed other potential proteins to be regulated by mir661 it would not be surprising to uncover
in the near future complimentary mechanisms through which this
miRNA regulates embryo-maternal adhesion. Anyhow, observations in
this work highlight the importance of miRNA molecules secreted by
the embryo in initiating the event of implantation.
Selection of the best embryo for transfer is imprecise and the current
methods involve morphologic criteria (Cruz et al., 2011), on the belief
that those with a better shape are more likely to be chromosomically
normal and implant. However, many morphologically normal blastocysts are aneuploid or will not implant (Fragouli et al., 2011) whilst embryos with an abnormal chromosomal content are able to do so. With
DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.003.
⁎ Corresponding author.
E-mail address: [email protected] (R. Gomez).
the development of transcriptomics and massive sequence analysis it
might be hypothetically possible to detect most of the genetic anomalies
in an embryo trough pre-implantation genetic screening (PGS). However such approach is invasive, expensive, and requires embryo biopsy
(Winand et al., 2014). Therefore in a world where the number of IVF
cycles increase every year, there is a growing clinical interest in understanding embryo-maternal interactions to identify biomarkers of
embryo quality. The purpose is obvious: to increase the pregnancy
rates per transfer and reduce the presence of anomalies in them.
These biomarkers are expected to allow noninvasive analysis, be stable
over time, specific to embryos, and easily measured. Due to the fact that
miRNAs accomplish these requirements, one might envision that the
expression levels of miR661 identified by Dimiatriadis and colleagues
in non-implanted blastocysts could be employed in the future in order
to screen and select for good quality embryos suitable for subsequent
uterine transfer.
Unfortunately, we have to lower our expectation in this regard just
now, as Cuman et al study was not intended to test the predictive
value of biomarkers identified during the exploratory process. Despite
the fact that the authors confirmed the overrepresentation of mir661
in a separate cohort of individual non-implanting blastocysts, the number of specimens analyzed was small. Moreover the experiment was not
designed to uncover the characteristics of non-implanted embryos. In
these regard, factors such as ploidy or genetic abnormalities were not
determined; indicators of low metabolic energy (Diez-Juan et al.,
2015) or embryo damage induced during ICSI (Rosenbluth et al.,
2014) were not estimated, and overall the contribution of several
other factors known to affect embryo outcome and its miRNA profile
(Galliano and Pellicer, 2014) were not assessed. So the question remaining is what population of non-implanted embryos overexpresses
mir661? In other words, does mir661 universally indicate embryos
fated to fail in implantation or just a very narrow and specific portion
of them? As this question remains unanswered, the repercussions in
terms of clinical usefulness of mir661 cannot currently be estimated.
This does not mean that we should neglect the potential of miR661
as a biomarker of embryo quality. It just means that further studies
should be performed to identify which specific aberrant and abnormal
embryo populations can be recognized by mir661 overexpression.
Subsequently larger double-blinded studies with an appropriate N
should be performed to test the accuracy of this marker as a predictor
http://dx.doi.org/10.1016/j.ebiom.2015.09.043
2352-3964/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A. Cano, R. Gomez / EBioMedicine 2 (2015) 1312–1313
of implantation outcome. As the title of this comment reflects, findings
provided by Cuman et al. in the context of embryo-maternal are of outstanding scientific interest. The repercussions these observations have
in the clinical context however might suppose a major breakthrough
and therefore well worth the effort in pursuing.
Conflict of Interest
The authors declare no conflicts of interest.
References
Balaguer, N., Vilella, F., Moreno-Moya, J.M., Herrero, M., Simon, C., 2015. Hsa-miR30d is transported by exosomes from human endometrial epithelium to the
trophectoderm of preimplantation embryos and modulates embryo adhesion.
Reprod. Sci. 22 (57A-57A).
Cruz, M., Gadea, B., Garrido, N., Pedersen, K.S., Martínez, M., Pérez-Cano, I., Muñoz, M.,
Meseguer, M., 2011. Embryo quality, blastocyst and ongoing pregnancy rates in oocyte donation patients whose embryos were monitored by time-lapse imaging.
J. Assist. Reprod. Genet. 28, 569–573.
1313
Cuman, C., Van Sinderen, M., Gantier, M.P., Rainczuk, K., Sorbya, K., Rombauts, L., Osianlis, T.,
Dimitriadis, E., 2015. Human blastocyst secreted microRNA regulate endometrial
epithelial cell adhesion. EBioMedicine 2, 1528–1535.
Diez-Juan, A., Rubio, C., Marin, C., Martinez, S., Al-Asmar, N., Riboldi, M., Díaz-Gimeno, P.,
Valbuena, D., Simón, C., 2015. Mitochondrial DNA content as a viability score in
human euploid embryos: less is better. Fertil. Steril. 104, 534–541.
Fragouli, E., Alfarawati, S., Daphnis, D.D., Goodall, N.N., Mania, A., Griffiths, T., Gordon, A.,
Wells, D., 2011. Cytogenetic analysis of human blastocysts with the use of FISH, CGH
and aCGH: scientific data and technical evaluation. Hum. Reprod. 26, 480–490.
Galliano, D., Pellicer, A., 2014. MicroRNA and implantation. Fertil. Steril. 101, 1531–1544.
Ng, Y.H., Rome, S., Jalabert, A., Forterre, A., Singh, H., Hincks, C.L., Salamonsen, L.A., 2013.
Endometrial exosomes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation. PLoS One 8, e58502.
Pellicer, A., Dominguez, F., Remohi, J., Simón, C., 2002. Molecular basis of implantation.
Reprod. BioMed. Online 5 (Suppl. 1), 44–51.
Rosenbluth, E.M., Shelton, D.N., Wells, L.M., Sparks, A.E., Van Voorhis, B.J., 2014. Human
embryos secrete micrornas into culture media—a potential biomarker for implantation. Fertil. Steril. 101, 1493–1500.
Winand, R., Hens, K., Dondorp, W., de Wert, G., Moreau, Y., Vermeesch, J.R., Liebaers, I.,
Aerts, J., 2014. In vitro screening of embryos by whole-genome sequencing: now, in
the future or never? Hum. Reprod. 29, 842–851.